Adverum Biotechnologies Inc (ADVM)
11.81
+0.28
(+2.43%)
USD |
NASDAQ |
Apr 16, 12:41
Adverum Biotechnologies 1 Year Total Returns (Daily): 37.26% for April 15, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| April 15, 2024 | 37.26% |
| April 12, 2024 | 56.40% |
| April 11, 2024 | 59.60% |
| April 10, 2024 | 66.41% |
| April 09, 2024 | 76.36% |
| April 08, 2024 | 84.73% |
| April 05, 2024 | 74.79% |
| April 04, 2024 | 88.14% |
| April 03, 2024 | 92.70% |
| April 02, 2024 | 86.79% |
| April 01, 2024 | 93.62% |
| March 28, 2024 | 76.75% |
| March 27, 2024 | 81.19% |
| March 26, 2024 | 86.75% |
| March 25, 2024 | 97.31% |
| March 22, 2024 | 105.9% |
| March 21, 2024 | 88.57% |
| March 20, 2024 | 93.31% |
| March 19, 2024 | 119.7% |
| March 18, 2024 | 135.7% |
| March 15, 2024 | 107.6% |
| March 14, 2024 | 119.0% |
| March 13, 2024 | 124.9% |
| March 12, 2024 | 129.1% |
| March 11, 2024 | 126.6% |
| Date | Value |
|---|---|
| March 08, 2024 | 127.1% |
| March 07, 2024 | 140.0% |
| March 06, 2024 | 141.5% |
| March 05, 2024 | 147.4% |
| March 04, 2024 | 159.2% |
| March 01, 2024 | 162.7% |
| February 29, 2024 | 175.0% |
| February 28, 2024 | 173.6% |
| February 27, 2024 | 185.7% |
| February 26, 2024 | 178.6% |
| February 23, 2024 | 185.7% |
| February 22, 2024 | 219.5% |
| February 21, 2024 | 204.2% |
| February 20, 2024 | 215.6% |
| February 16, 2024 | 221.2% |
| February 15, 2024 | 221.4% |
| February 14, 2024 | 235.6% |
| February 13, 2024 | 267.8% |
| February 12, 2024 | 216.6% |
| February 09, 2024 | 162.1% |
| February 08, 2024 | 198.1% |
| February 07, 2024 | 308.4% |
| February 06, 2024 | 261.3% |
| February 05, 2024 | 172.9% |
| February 02, 2024 | 103.2% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-90.25%
Minimum
Feb 23 2022
351.1%
Maximum
Feb 14 2020
16.25%
Average
7.60%
Median
1 Year Total Returns (Daily) Benchmarks
| Karyopharm Therapeutics Inc | -73.38% |
| Ardelyx Inc | 44.59% |
| Minerva Neurosciences Inc | 6.14% |
| Arcutis Biotherapeutics Inc | -27.47% |
| 4D Molecular Therapeutics Inc | 62.09% |